23andMe Holding Co. (ME) financial statements (2022 and earlier)

Company profile

Business Address 223 NORTH MATHILDA AVENUE
SUNNYVALE, CA 94086
State of Incorp.
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
TTM
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5861
Cash and cash equivalents5861
Restricted cash and investments2 
Receivables24 
Inventory, net of allowances, customer advances and progress billings17 
Inventory17 
Prepaid expense 0
Deferred costs16 
Other undisclosed current assets25 
Total current assets:6701
Noncurrent Assets
Operating lease, right-of-use asset57 
Property, plant and equipment52 
Intangible assets, net (including goodwill)430 
Goodwill352 
Intangible assets, net (excluding goodwill)78 
Assets held-in-trust 509
Restricted cash and investments7 
Other noncurrent assets1 
Other undisclosed noncurrent assets8 
Total noncurrent assets:556509
TOTAL ASSETS:1,226510
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities610
Accounts payable14 
Accrued liabilities460
Deferred revenue112 
Debt 2
Deferred compensation liability 18
Other undisclosed current liabilities7 
Total current liabilities:18019
Noncurrent Liabilities
Long-term debt and lease obligation81 
Operating lease, liability81 
Liabilities, other than long-term debt5 
Other liabilities5 
Total noncurrent liabilities:86 
Other undisclosed liabilities 69
Total liabilities:26588
Stockholders' equity
Stockholders' equity attributable to parent, including:9615
Common stock00
Additional paid in capital2,08654
Accumulated other comprehensive loss(0) 
Accumulated deficit(1,125)(49)
Other undisclosed stockholders' equity attributable to parent 0
Other undisclosed stockholders' equity 417
Total stockholders' equity:961422
TOTAL LIABILITIES AND EQUITY:1,226510

Income statement (P&L) ($ in millions)

12/31/2021
TTM
12/31/2020
Revenues171 
Revenue from related parties29 
Cost of revenue(85) 
Gross profit:86 
Operating expenses(273) 
Other undisclosed operating income0 
Operating loss:(187) 
Nonoperating income25 
Other undisclosed income from continuing operations before equity method investments, income taxes0 
Loss from continuing operations before equity method investments, income taxes:(162) 
Other undisclosed income from continuing operations before income taxes4 
Loss from continuing operations before income taxes:(158) 
Income tax benefit4 
Net loss:(155) 
Other undisclosed net income attributable to parent30 
Net loss available to common stockholders, diluted:(125) 

Comprehensive Income ($ in millions)

12/31/2021
TTM
12/31/2020
Net loss:(155) 
Other comprehensive loss(0) 
Comprehensive loss, net of tax, attributable to parent:(155) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: